<DOC>
	<DOCNO>NCT01315002</DOCNO>
	<brief_summary>The purpose study test effect nicotine cognition follow schizophrenia endophenotypes : prepulse inhibition , antisaccades , continuous performance test , spatial work memory verbal memory task . Schizophrenia patient , unaffected first-degree relative schizophrenia patient healthy control receive transdermal nicotine double-blind , placebo-controlled , crossover study .</brief_summary>
	<brief_title>Nicotine Effects Endophenotypes Schizophrenia</brief_title>
	<detailed_description>Convergent finding suggest alter neuronal nicotinic acetylcholine receptor system may contribute pathophysiology schizophrenia . Nicotine consumption cigarette smoking might represent form self-medication schizophrenia nicotine reduces cognitive physiological deficit schizophrenia . The present study aim investigate nicotine affect attentional executive schizophrenia endophenotypes genetic polymorphism relate cholinergic system might play role inter-individual difference magnitude nicotine effect . Schizophrenia patient , first-degree relative schizophrenia patient well healthy control receive transdermal nicotine double-blind , placebo-controlled , crossover study assess prepulse inhibition , antisaccades , continuous performance test , spatial work memory verbal memory task . Subjects overnight-abstinent smoker non-smokers . However , investigator particularly test non-smokers order eliminate confounding effect nicotine withdrawal reinstatement . Main hypothesis : - Schizophrenia patient perform bad match control cognitive test ( validate endophenotypes ) . - Nicotine administration enhance cognitive performance overnight-abstinent smoker . - Improvement cognitive performance smoker schizophrenia strong control smoker . - Improvement cognitive performance smoke first-degree relative schizophrenia patient strong control smoker . - Nicotine administration affect cognitive function non-smoking subject . - Nicotine administration improve cognitive function non-smoking schizophrenia patient . - The effect nicotine non-smoking subject strong subject cognitively impaired ( i.e . perform median respective group ) . The present research contribute issue whether nicotinic cholinergic receptor agonist may therapeutic value treatment cognition schizophrenia .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Patients : Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSM IV ) diagnosis schizophrenia age 1855 year old able provide inform consent treat antipsychotic medication stable dose least 6 week normal correct normal vision smoker ( Fagerström Test Nicotine Dependence &gt; 4 ) nonsmoker ( &lt; 100 cigarettes/lifetime , smoke past year ) Controls : age 1855 year old able provide inform consent normal correct normal vision smoker ( Fagerström Test Nicotine Dependence &gt; 4 ) nonsmoker ( &lt; 100 cigarettes/lifetime , smoke past year ) Unaffected FirstDegree Relatives Schizophrenia Patients : inclusion criterion control plus adult firstdegree relative ( sibling , parent , child ) DSM IV diagnosis schizophrenia Patients : substance dependence clinical instability change medication last 6 week anticholinergic medication untreated hypertension cardiovascular disease insulindependent diabetes mellitus phaeochromocytoma uncontrolled hyperthyroidism renal hepatic impairment central nervous system disease pulmonary disease generalise dermatological disorder ( neurodermatitis , psoriasis , chronic dermatitis , urticaria , etc . ) gastric intestinal ulcer hypersensitivity nicotine allergy patch woman : pregnancy , lactation Controls : substance dependence first , second , thirddegree relative psychotic disorder DSM IV Axis I disorder anticholinergic medication untreated hypertension cardiovascular disease insulindependent diabetes mellitus phaeochromocytoma uncontrolled hyperthyroidism renal hepatic impairment central nervous system disease pulmonary disease generalise dermatological disorder ( neurodermatitis , psoriasis , chronic dermatitis , urticaria , etc . ) gastric intestinal ulcer hypersensitivity nicotine allergy patch woman : pregnancy , lactation Unaffected FirstDegree Relatives Schizophrenia Patients : exclusion criterion control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>nicotine</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>endophenotype</keyword>
</DOC>